Several analysts have recently updated their ratings and price targets for AON (NYSE: AON): 9/21/2026 – AON is now covered by Citigroup Inc.. They set a “buy” rating and a $435.00 price target on the stock. 9/17/2026 – AON was downgraded by Weiss Ratings from “hold (c+)” to “hold (c)”. 9/16/2026 – AON had its […]

Palantir Technologies (NASDAQ: PLTR) has recently received a number of price target changes and ratings updates: 9/23/2026 – Palantir Technologies had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $225.00 price target on the stock. 9/15/2026 – Palantir Technologies had its price target raised by UBS Group AG from $220.00 to $250.00. […]

A number of research firms have changed their ratings and price targets for Xenon Pharmaceuticals (NASDAQ: XENE): 9/19/2026 – Xenon Pharmaceuticals was downgraded by Wall Street Zen from “sell” to “strong sell”. 9/18/2026 – Xenon Pharmaceuticals had its “buy” rating reaffirmed by HC Wainwright. 9/18/2026 – Xenon Pharmaceuticals had its price target lowered by Wells […]

A number of firms have modified their ratings and price targets on shares of Teva Pharmaceutical Industries (NYSE: TEVA) recently: 9/23/2026 – Teva Pharmaceutical Industries is now covered by Oppenheimer Holdings, Inc.. They set an “outperform” rating and a $50.00 price target on the stock. 9/9/2026 – Teva Pharmaceutical Industries is now covered by Leerink […]